epitalon epithalon market availability and dosing Capsules Epithalon | Reviews, Clinical Trials,
Description
827 TABLE 15
But plausibility isn't proof
SALT score dropped from 40% to 7.5% The median SALT score decreased from 40.0% (IQR: 23.8%50.0%) at baseline to 7.5% (IQR: 0%17.5%) after 5 sessions
Indications Peripheral neuropathies such as diabetic neuropathy, entrapment neuropathy, diabetic retinopathy, and other neuropathies
Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy
([PMC][2]) 3
